-
Blue Sail Medical’s Fastroad Catheter Earns NMPA Marketing Approval
•
Blue Sail Medical Co., Ltd (SHE: 002382), a medical device company based in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its Category III medical device, Fastroad. Fastroad is a distal pathway catheter designed for radial artery neurovascular access and was…
-
Blue Sail Medical Receives NMPA Approval for Disposable Coronary Intravascular Impact Waveguide
•
China’s Blue Sail Medical Co., Ltd (SHE: 002382) has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its disposable coronary intravascular impact waveguide, SoniCracker CL. This product is designed to be used in conjunction with the company’s proprietary coronary intravascular shock wave therapy…
-
Blue Sail Medical Subsidiary Secures RMB 100 Million Investment to Expand Operations
•
China’s Blue Sail Medical Co., Ltd (SHE: 002382) has announced that Blue Sail Biosensors Medical Technology, its wholly-owned subsidiary, has introduced a strategic investor, Beijing Daxing Airport Economic Zone Development Fund. The fund has made a substantial investment of RMB 100 million (USD 14 million) in the company. The proceeds…
-
Blue Sail Medical’s New Catheter Receives NMPA Approval for Complex Coronary Lesion Treatment
•
China’s Blue Sail Medical Co., Ltd (SHE: 002382) has received marketing approval from the National Medical Products Administration (NMPA) for its new coronary artery balloon dilation catheter, classified as a Category III medical device. This development marks a significant step forward in the treatment of complex coronary artery lesions, including…
-
Blue Sail Medical Secures RMB 900 Million Investment for R&D and Capacity Expansion
•
Blue Sail Medical Co., Ltd (SHE: 002382) has announced that its wholly owned subsidiary, Blue Sail Biosensors Medical Technology, has secured strategic investments totaling RMB 900 million from Capital Health Industry (Beijing) Fund and two other investors. The funds will be allocated to enhance product research and development as well…
-
Blue Sail Medical Partners with Weifang Government on Healthcare Initiative
•
China’s Blue Sail Medical Co., Ltd. (SHE: 002382) has announced strategic cooperation agreements with the local government of Weifang, Shandong province, as well as Linqu county, also within Weifang. Under this partnership, the Weifang government plans to invest in Blue Sail, facilitating the introduction of various medical and healthcare-related projects…
-
Blue Sail Medical and China National Medical Device Forge Strategic Partnership for Growth
•
Blue Sail Medical Co., Ltd (SHE: 002382), a prominent player in China’s medical device sector, has announced a cooperation framework agreement with fellow domestic firm China National Medical Device Co., Ltd. The partnership aims to capitalize on the respective strengths of both companies, focusing on market channels, product offerings, brand…
-
Blue Sail Medical Enrolls First Patient in Study for Rapamycin-Coated Balloon Catheter
•
China’s Blue Sail Medical Co., Ltd (SHE: 002382) has announced a significant milestone with the enrollment of the first patient in a prospective, multi-center, randomized controlled clinical study. The study is designed to assess the efficacy and safety of Blue Sail Medical’s rapamycin-coated balloon dilation catheter for arteriovenous fistula in…
